Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review

Vikram Narayan, Philipp Dahm, Nicole Skoetz, Michael C. Risk, Connie Bongiorno, Neil Patel, Jae Hung Jung, Gerald Gartlehner, Frank Kunath

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of pembrolizumab monotherapy versus chemotherapy for the second-line treatment of advanced urothelial carcinoma.

Original languageEnglish
Article numberCD012838
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number11
DOIs
Publication statusPublished - 2017 Nov 1

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this